2021 Herston Healthcare Symposium
Wednesday 8 September 2021
Time Stamp | Description |
---|---|
Oral Presentations
Welcome & Introduction Dr Merrilyn Banks, Director, Nutrition & Dietetics |
|
3.05min | Managing intravenous devices among patients with limited vascular access or prolonged therapy: a pilot randomised control trial
Nicole Marsh |
10.31min | A first in human study to investigate the safety, pharmacokinetics and antimalarial activity of ZY-19489 in healthy volunteers inoculated with blood-stage Plasmodium falciparum
Bridget Barber |
17.40min | Risk factors for central venous access device failure: a multivariable analysis of 1893 catheters
Amanda Corley |
25.15min | Single Breath Count Test (SBCT) for the assessment of pulmonary function in patients with chest trauma
Brett Parfitt |
31.13min | Medication harm causing unplanned hospital presentation or admission after Acute Myocardial Infarction Chariclia Paradissis
Chariclia Paradissis |
39.03min | CT Brain Scan Utilisation in Patients with a Headache presenting to EDs across Australia and New Zealand Kevin Chu
Kevin Chu |
46.10min | Two Treponema pallidum strains account for the majority of Syphilis infections, including among females, in Queensland: the need for targeted interventions?
Emma Sweeney |
55.23min | Depression and anxiety symptoms in the first months of the COVID-19 pandemic in Queensland
Lucía Colodro-Conde |
61.58min | Development of a new tool to monitor and identify inadequate oral intake in hospital
Adrienne Young |
69.28min | Enhancing individualised treatment for Mycoplasma genitalium infection
Jacob Tickner |
75.52min | The effectiveness of Indigenous youth health assessments: A narrative systematic review
Jed Fraser |
85.00min | Integrated versus nOn-integrated Peripheral inTravenous catheter in hospitalised adults (OPTIMUM) study: A randomized controlled trial
Claire Rickard |
94.10min | Closing Statement
Dr Merrilyn Banks, Director, Nutrition & Dietetics, RBWH |
KEYNOTE LECTURE: “THE HEALTH DATA ECOSYSTEM IN 2030: INTEROPERABILITY, SMART APPS AND MORE”
Welcome & Introduction David Hanson, Director, CSIRO |
|
7.27min | Interoperability
Kate Ebrill, Clinical Terminology Product Manager, CSIRO |
20.30min | Interoperability
Michael Lawley, Health Informatics Group Leader, CSIRO |
31.12min | Apps and Personalisation
Jim Steel, Health data and FHIR Team Leader, CSIRO |
40.15min | Data analytics as a service
Marlien Varnfield, Team Leader – Mobile Health Systems. |
48.00min | Where to with Apps
Jim Steel, Health data and FHIR Team Leader, CSIRO |
49.40min | Questions & Answers |
HOW FAR HAS MEDICAL INNOVATION FULFILLED ITS PROMISES OF THE LAST 20 YEARS?
Welcome & Introduction Professor Michael Reade, Consultant Intensive Care Physician. Department of Intensive Care Medicine, RBWH & Mayne Professor of Critical Care, University of Queensland |
|
2:45min | CELL AND GENE THERAPY FOR BLOOD DISEASES
Dr Siok Tey, Staff Specialist, Clinical Haematology, Cancer Care Services, RBWH |
20:10min | NEUROLOGY
Dr Helen Brown, Clinical Director of the Neuroscience Division, RBWH |
35:20min | ENDOCRINOLOGY
Dr Michael d’Emden, Director of Endocrinology, RBWH |
51:00min | CARDIOLOGY
Dr Paul Martin, Medical Officer, Cardiology Department, RBWH |
1:06:20min | DIAGNOSTIC MICROBIOLOGY
Dr Patrick Harris, Acting State-wide Director of Microbiology Pathology QLD & UQCCR |
1:19:55min | PHARMACY
Professor Jason Roberts, Interim Director, HeIDI & Pharmacist, RBWH |
1:34:30min | RADIOGRAPHY
Christine McHenery, Radiographer, Medical Imaging, RBWH |
1:48:08min | PATHOLOGY
Professor Sunil Lakhani, Executive Director Research, Pathology QLD and Head of Breast Group, UQCCR, Pathology Queensland & University of Qld |
2:01:30min | Q & A / Closing Statement
Professor Michael Reade, Consultant Intensive Care Physician. Department of Intensive Care Medicine, RBWH & Mayne Professor of Critical Care, University of Queensland |
INTERPRETING AND MANAGING GENETIC ABNORMALITIES IN DISEASE- CASE STUDIES AND A GENOMIC MDT PRESENTATION
Welcome & Introduction Associate Professor David Fielding, Thoracic Physician, Department of Thoracic Medicine, RBWH |
|
3:45min | Path QLD Service for Common Genomic abnormalities in cancer – Somatic
David Fairbairn, Advanced Scientist, Molecular Genetics, Pathology Queensland |
21:00min | Path Qld Service for common Genomic abnormalities – Myeloid
Louise Seymour, Haematologist, Pathology Queensland |
37:40min | Clinical Case Discussion – Infectious Disease
Dr Patrick Harris, Acting Director Microbiology, Pathology Queensland |
54:20min | Clinical Case Discussion – Brain & Lung
Associate Professor Zarnie Lwin, Senior Staff Specialist Medical Oncology, Cancer Care Services, RBWH |
1:05:15min | Clinical Case Discussion – Breast Cancer
Associate Professor Peter Simpson, UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland |
1:19:02min | The potential of whole genome sequencing – hardware and software aspects
John Pearson, Manager, Genome Informatics, Queensland Institute of Medical Research, QIMR Berghofer |
1:34:55min | The potential of whole Genome sequencing – clinical aspects
Dr Nic Waddell, Group Leader, Coordinator of Cancer Program, Queensland Institute of Medical Research, QIMR Berghofer |
1:49:50min | Panel Discussion |
Education Sessions
Time Stamp | Description |
---|---|
12:30pm CLINICAL REGISTRY DEVELOPMENT WITHIN METRO NORTH |
|
Welcome & Introduction Brett Droder, Health Information Manager, Jamieson Trauma Institute, RBWH |
|
00:47sec | Discussion Points (Clinical Registry Development Experience) Brett Droder, Health Information Manager, Jamieson Trauma Institute, RBWH |
33:00min | Q & A |
56:30min | Metro North REDCap Roxanne Machen, Metro North REDCap System Administrator |
1:12:50min | Q & A |